ClinicalTrials.Veeva

Menu

Magnesium Supplementation in Stress Conditions

P

Protina Pharmazeutische GmbH

Status

Completed

Conditions

Stress Physiology

Treatments

Dietary Supplement: Magnesium
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03203096
StressMag2017

Details and patient eligibility

About

This study aims to determine how a 6-week magnesium supplementation with 400 mg magnesium from magnesium citrate/magnesium oxide affects stress parameters in students in exam preparation.

Full description

The examinations are carried out in 70 students in exam preparation (6 weeks before exam). The target parameters are determined in blood and 24h-urine. Blood sampling takes place at confinement, after 3 weeks and at the end of the study (week 6). In addition, heart rate variability is determined.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy students in exam preparation

Exclusion criteria

  • pregnancy
  • any chronic diseases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

70 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
identically tasting and looking Placebo
Treatment:
Dietary Supplement: Placebo
Magnesium
Active Comparator group
Description:
Supplementation with 400 mg Magnesium from Magnesium Citrate / Magnesium Oxide once daily
Treatment:
Dietary Supplement: Magnesium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems